Digital health’s Q3 saw the lowest quarterly funding total in the past 11 quarters, but experts don't think this trend should be a cause for concern. They said it's important to remember that the mega-boom of 2020 and 2021 was an anomaly for the sector.
VCs at MedCity INVEST Digital Health said there’s no shortage of interesting digital health companies, even ones that can prove their innovations are effective. The challenge is winning over insurers and physicians, and finding payment models that work.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
The healthcare conference, held in a virtual format due to Covid-19, brings together innovative investors across the healthcare spectrum, prominent industry players and the most promising digital health startups.
The startup, which is focused on letting patients share their health records for rare disease research, plans to use the funds to launch 100 rare disease programs.
The study design is still being finalized, and the company is thus not yet divulging too many details. However, CEO David Daly said it would be significantly larger than the previous DETECT-A, multi-center and would include both men and women.
The San Francisco-based startup is one of several that have been raising money over the past couple of weeks in areas like neurology, oncology and women's health.
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
Roughly 30 percent to 40 percent of the new fund will in some way "touch the healthcare vertical", said Adam Goulburn, a partner with the firm, in response to emailed questions.
Among his takeaways from J.P. Morgan, Lux Capital Partner Adam Goulburn said "Early stage investors are wary...It feels like most have pressed pause and are in hold mode."
It will use the funding to advance its approach which it describes as somewhere between a communication device and an EHR.
Auris Surgical Robotics just raised an impressive $150 million Series B, ostensibly to develop its eye surgery robot. The company's been backed by the Peter Thiel venture firm Mithril Capital Management.
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
Lux Capital has finally announced it has raised a $350 million fund. It made the announcement through a blog post on Medium that veered between sci-fy fanboy enthusiasm and bullishness for emerging developments in robotics, 3D printing, and biotech. It comes a couple of months after a Form D filing regarding the fund and some speculation […]
Lux Capital is raising a $350 million fund, Lux Ventures 4, as Fierce Biotech has already noted. From my standpoint, without confirmation from the firm, it’s entirely possible that war chest will be used to invest in digital health and biotech companies. It also invests in energy and technology companies. But here’s a look at […]
I read an interesting Wall Street Journal article recently that discussed the war between tech companies to control future consumer distribution platforms. The article explains that the cash-flush giants “…each want to own the digital platform where people communicate, shop and seek entertainment.” This got me thinking about platforms in healthcare. Right now, it’s fair […]